"Well the good news is, it's happened already and it was "productive". And the bad news is it wasn't productive enough for the company to share the results with investors..."
There's going to be another trial. That is productive. And years. Unproductive would be that this is not another trial. I'm guessing you're Australian?
"Remember way back when "second generation rexlemestrocel-L in late stage development for the treatment of chronic low back pain (CLBP)" was actually meant to repair the Degenerative Disc Disease (DDD) itself, not just treat the pain...."
Chronic Discogenic Low Back Pain - Mesoblast Ltd
You don't have to go back in time to remember. You disagree? Based on what?
banter and General Discussion, page-7598
-
- There are more pages in this discussion • 3,473 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |